|
|
|
Bad Breath Cause & Cure
Bad Breath Cause & Cure Copyright 2004 www.FatFreeKitchen.com [You have permission to publish this article in your web sites, ezines or electronic publication, as long as the piece is used in its entirety including the resource box, all HTML...
Diabetes: Alzheimer's and Diabetes Could Be Linked Diseases II
The group of researchers from Brown University Medical School
analyzed, in the frontal part of the brain, one of the major
area affected by Alzheimer's, insulin and insulin receptor
function.
The team discovered that the levels of insulin...
Medical Supply Cases for Insulin and Diabetics
Medical supply manufacturers are continuously conceptualizing medical supplies needed by people who are in delicate health condition – medical supplies that may enable the patient to lead a life with at least a semblance of normalcy. Diabetic...
The Uninsured Are Sicker And Die Sooner part 2
If common childhood conditions such as asthma, anemia, and middle-ear infections are left untreated or improperly controlled — which can happen if a family lacks insurance — they can affect mental and language development, school performance, and...
TraditionaL ayurvedic medicine for type two diabetes (salacia oblonga)
Salacia oblonga Indian herb also known as Ponkoranti. It has been used by Indian natives since ancient times to effectively manage Diabetes. This is a effective cure for type 2 diabetes. Reduction in blood sugar levels can be observed within 5...
|
|
| |
|
|
|
|
|
|
Eli Lilly to pay $700 million to Zyprexa Victims
Eli Lilly to pay $700 million to Zyprexa Victims
On June 9th, 2005 Eli Lilly and Company announced that it has entered an agreement with plaintiffs’ attorneys involved in Zyprexa liability litigation to settle most of the claims against the company relating to their Zyprexa medication.
"While we believe the claims are without merit, we took this difficult step because we believe it is in the best interest of the company, the patients who depend on this medication, and their doctors," said Sidney Taurel, chairman, president and chief executive officer of Eli Lilly and Company.
The agreement states that Eli Lilly will establish a fund of $690 million for plaintiffs who agree to settle their claims. This settlement fund will be overlooked and distributed by claims administrators chosen by the steering committee of the plaintiffs. At this time the number of claimants is projected at around 8,000 comprising about 75% of claims identified to
Lilly.
This agreement involves claimants who have allegedly developed diabetes-related side effects from their use of the drug Zyprexa. Those who are not covered by the final settlement are those who are represented by attorneys not participating in the agreement in principle. Lilly is ready to continue their forceful defense of Zyprexa in the remaining cases.
Investors have been advised that at least $700 million pretax will be taken in the 2nd quarter of 2005 to cover this settlement and as well as other product liability claims.
To learn more about this recent Zyprexa settlement by Eli Lilly and Company please visit http://www.resource4zyprexainfo.com
About the Author
This article may be freely re-printed as long as this resource box is included and all links stay intact as hyper-links. To learn more about hiring a Zyprexa lawyer please visit http://www.resource4zyprexainfo.com
|
|
|
|
|
|